esmolol hydrochloride double strength in plastic container Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Esmolol Hydrochloride Double Strength In Plastic Container, and what generic alternatives are available?
Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are two patents protecting this drug.
This drug has seven patent family members in seven countries.
The generic ingredient in ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Esmolol Hydrochloride Double Strength In Plastic Container
A generic version of esmolol hydrochloride double strength in plastic container was approved as esmolol hydrochloride by HIKMA on August 10th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for esmolol hydrochloride double strength in plastic container?
- What are the global sales for esmolol hydrochloride double strength in plastic container?
- What is Average Wholesale Price for esmolol hydrochloride double strength in plastic container?
Summary for esmolol hydrochloride double strength in plastic container
| International Patents: | 7 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 112 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for esmolol hydrochloride double strength in plastic container |
| DailyMed Link: | esmolol hydrochloride double strength in plastic container at DailyMed |
Recent Clinical Trials for esmolol hydrochloride double strength in plastic container
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Muhammad Haroon Anwar | Phase 4 |
| Pakistan Institute of Medical Sciences | Phase 4 |
| Instituto de Salud Carlos III | Phase 3 |
See all esmolol hydrochloride double strength in plastic container clinical trials
Pharmacology for esmolol hydrochloride double strength in plastic container
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
US Patents and Regulatory Information for esmolol hydrochloride double strength in plastic container
esmolol hydrochloride double strength in plastic container is protected by two US patents.
Patents protecting esmolol hydrochloride double strength in plastic container
Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hq Spclt Pharma | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER | esmolol hydrochloride | SOLUTION;INTRAVENOUS | 205703-002 | Apr 7, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hq Spclt Pharma | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER | esmolol hydrochloride | SOLUTION;INTRAVENOUS | 205703-002 | Apr 7, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for esmolol hydrochloride double strength in plastic container
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hq Spclt Pharma | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER | esmolol hydrochloride | SOLUTION;INTRAVENOUS | 205703-002 | Apr 7, 2016 | ⤷ Sign Up | ⤷ Sign Up |
| Hq Spclt Pharma | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER | esmolol hydrochloride | SOLUTION;INTRAVENOUS | 205703-002 | Apr 7, 2016 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for esmolol hydrochloride double strength in plastic container
See the table below for patents covering esmolol hydrochloride double strength in plastic container around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
